Answers are grounded in this paper and cite their sources.
Explores outcomes of post-transplant lymphoproliferative disease in transplant patients, highlighting its severe risks.
Post-transplant lymphoproliferative disease is a major and life-threatening complication of chronic immunosuppression therapy following solid organ transplant and hematopoietic stem cell transplantation. It is commonly associated with Epstein-Barr virus infection and affects patients bimodally in the first year or 4-5 years post-transplant. US, MRI, CT, and PET-CT can be used to identify, stage, and follow the disease.
No takes yet. Share an insight, caveat, or question.
Reyes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: